Breakthrough: AI Designs a ‘Pandemic-Proof’ Vaccine
Scientists at the University of Cambridge, with the help of artificial intelligence (AI), have created vaccine technology for a ‘universal’ coronavirus vaccine. Revealed on June 5, 2026, it can protect against thousands of variants—even those we don't know about yet—potentially stopping pandemics before they begin.
How It Works: Targeting Shared Virus Features
Traditional vaccines use specific antigens from known strains. This new “super-antigen” jab uses machine learning to analyze past and current outbreaks, identifying proteins common across entire virus families. Sticking these together teaches the immune system to attack any virus containing those targets.
Clinical Trial: Safe with Broad Immune Response
A “world-first” human trial (Phase I) of the jab involved 49 healthy volunteers aged 18–50. Results showed the vaccine is safe and triggers a strong immune response against SARS, Covid-19, and related bat coronaviruses. The vaccine was administered via a needle-free micro fluid jet that pushes the blueprint directly into skin cells.
Expert Opinion: From Reactive to Proactive
Professor Saul Faust (University of Southampton) said: “If we can develop these before an outbreak, millions of lives could be saved, lockdowns avoided, and the economy preserved.” Professor Jonathan Heeney (Cambridge) called the tech a “game changer,” making vaccines “far better, broader, and more robust.” Over 200 volunteers are being recruited for Phase II.